Khaleej Times Online >> News >> CITY TIMES

30 October 2005

The Gulf Pharmaceuticals Company (Julphar) has expressed its readiness to produce anti-avian flu medication in association with a Swiss pharmaceutical company. Julphar's top-informed official said that both companies are ready to produce the medicine and are waiting ...

for necessary permissions from health-care authorities in the country.

"We are ready to produce the country's requirements of the Tama Flu vaccine provided we are given the green signal by concerned national bodies," Abdulrazaq Yousif, Julphar managing director, said in a Press conference held on Thursday night. The WHO-adopted drug is considered to be the only formula against the H5N1 virus that is expected to cause the bird flu pandemic.

Yousif mentioned that Julphar has the capacity to produce the drug. "Due to the huge world demand, the Swiss company Roche can't provide any country with its needs of the medicine in less than six months, whereas we will be able to do that in less than four weeks."

►Back      ►Print